Empower Clinician Information | Natera

Testing Simplified

Empower includes genes associated with common hereditary cancers

Actionable Reports

Patient management recommendations based on medical guidelines

Actionable Reports

Patient management recommendations based on medical guidelines

The Empower Hereditary Cancer Test is Designed with Your Practice in Mind

Panels include genes associated with increased risk for common hereditary cancers.


Actionable reports to guide next steps, including:

  • Screenings that detect cancer at its earliest, most treatable stage

  • Risk-reducing medications and surgeries

  • Surgical or therapeutic decisions for patients diagnosed with cancer

  • Informing family members to help them proactively manage hereditary cancer risk

Support every step of the way

We make testing fit seamlessly into your workflow with a flexible selection of tools and services for every point of the patient journey.

Learn more about NateraCore services.


Natera is committed to patient affordability

Natera is pleased to be an in-network provider with most health plans, including Aetna, Anthem, Cigna, and UnitedHealthcare.

For patients without adequate insurance coverage, Natera also offers self-pay pricing and compassionate care options.

View our Pricing and Billing page

Patients could meet guidelines for hereditary cancer testing1
1 in 4
Women who will be affected by breast cancer in their lifetime2
1 in 8
Percent of all cancers believed to be caused by inherited mutations3
5 - 10%

Many patients at high risk for hereditary cancer are not tested

of women at "high risk" for hereditary breast or ovarian cancer never discussed genetic testing with their health care provider4

of individuals at risk for Lynch syndrome were never advised by their health care provider to undergo genetic testing5

When to consider hereditary cancer testing6


Is Empower right for you? Contact us.


  1. DeFrancesco et al. (2018) Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting. Obstet Gynecol. 132(5):1121-1129.
  2. American Cancer Society. How Common Is Breast Cancer? Jan. 2020. Available here.
  3. Genetic Testing for Inherited Cancer Susceptibility Syndromes, National Cancer Institute. March 2019. Available here.
  4. Bellcross CA, Peipins LA, McCarty FA, Rodriguez JL, et al. Genet Med. Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system. 2015 Jan;17(1):43–50.
  5. Patel SG, Ahnen DJ, Kinney AY, et al. Am J Gastroenterol. Knowledge and uptake of genetic counseling and colonoscopic screening among individuals at increased risk for lynch syndrome and their endoscopists from the family health promotion project. 2016 Feb;111(2):285-93.
  6. NCCN Clinical Practice Guidelines in Oncology Genetic/Familial High Risk Assessment: Breast, Ovarian and Pancreatic v1.2020